SCHEMBL20109159

SCHEMBL20109159

CC/C(=C\c1ccccc1)P1(=O)OCCO1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.40
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.38
NPC1 O15118 1/20 0.38
NR1I2 O75469 1/20 0.37
ALDH1A1 P00352 2/20 0.37
TSHR P16473 1/20 0.37
AKR1C3 P42330 1/20 0.37
MAPT P10636 2/20 0.37
CYP2C9 P11712 2/20 0.37
CYP1A2 P05177 1/20 0.37
HPGD P15428 1/20 0.37
CYP2C19 P33261 1/20 0.37
HSD17B10 Q99714 1/20 0.37
LMNA P02545 2/20 0.36
RECQL P46063 1/20 0.36
TDP1 Q9NUW8 2/20 0.36
HTT P42858 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20109183 0.74 KDM1A (0.40) KDM1AMEN1KMT2AL3MBTL1NPC1
SCHEMBL20109133 0.71 TSHR (0.40) KDM1AMEN1KMT2ANPC1NR1I2
Oxirane SCHEMBL15646744 0.67 CYP3A4 (0.54) KDM1AMEN1KMT2AAKR1C3CYP2C9
SCHEMBL20109208 0.65 SMN1; SMN2 (0.40) KDM1AMEN1KMT2ANPC1NR1I2
SCHEMBL20109235 0.65 SMN1; SMN2 (0.40) KDM1AMEN1KMT2ANPC1NR1I2
SCHEMBL59713 0.64 KDM1A (0.48) KDM1AMEN1KMT2ANR1I2ALDH1A1
SCHEMBL7855199 0.64 KDM1A (0.48) KDM1AMEN1KMT2ANR1I2ALDH1A1
SCHEMBL8038875 0.64 MEN1 (0.63) MEN1KMT2ANR1I2ALDH1A1TSHR
SCHEMBL23112863 0.63 FBP1 (0.61) KDM1AMEN1KMT2ANR1I2ALDH1A1
SCHEMBL8137951 0.63 FBP1 (0.61) KDM1AMEN1KMT2ANR1I2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180118770-A1 N-Heterocyclic Phosphines THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS 2018-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180118770-A1 N-Heterocyclic Phosphines NANP, PPIP5K2, PHPT1 KDM1A 4434/4885MEN1 469/4885KMT2A 2508/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.